Most people think of Vitamin D in the context of bones, or the immune system. But a new study suggests that it may also have a connection to brain health, long before memory problems appear.
The study, which relied on participants from the famous Framingham Study, examined people without dementia whose blood Vitamin D levels were measured when they were, on average, 39 years old. Approximately 16 years later, the participants underwent advanced brain PET scans designed to identify two biomarkers associated with Alzheimer's: Amyloid and tau.
The main finding was intriguing: The higher the Vitamin D levels were at an earlier age in midlife, the less accumulation of tau protein was observed in the brain years later. Tau is one of the main proteins involved in Alzheimer's disease, and its accumulation in certain areas of the brain is considered an important marker of a degenerative process.
Conversely, the researchers found no connection between Vitamin D levels and the accumulation of amyloid, another protein linked to Alzheimer's.
It is important to state right at the outset: The study does not prove that Vitamin D prevents dementia. Nor does it prove that a Vitamin D supplement can prevent Alzheimer's. But it does join a growing body of research showing that brain health in older age may be affected by factors that begin to operate decades earlier, and some of them are modifiable.
What Did the Researchers Examine?
The researchers used data from the Framingham Study, one of the world's most important and longest-running population studies in the field of heart and brain health. The participants in the current study were without dementia, stroke, or known neurological diseases.
Between the years 2002 and 2005, Vitamin D levels were measured in their blood. Years later, between 2016 and 2019, the participants underwent brain PET scans.
The PET scans examined two types of accumulation in the brain. The first was amyloid, a protein that has been studied for many years in the context of Alzheimer's. The second was tau, primarily in regions considered sensitive during the early stages of the disease, such as areas in the temporal lobe, and the amygdala.
In total, the study included hundreds of participants with available Vitamin D data and PET scans. The average age at the time of Vitamin D measurement was 39, and the average time between the blood test and the brain scan was about 16 years. About a third of the participants had Vitamin D levels below 30 ng/mL.
To reduce bias, the researchers adjusted the analysis for many factors that might affect the results: Age, sex, the season of the year in which the blood test was taken, depression, smoking, blood pressure, use of blood pressure medications, diabetes, cardiovascular diseases, BMI, the time that elapsed until the PET scan, and the type of PET scanner.
What Was Found in the Study?
The main finding was that the higher the Vitamin D levels were at the beginning of midlife, the less tau accumulation was observed in the brain years later.
This connection also appeared when the researchers examined the overall amount of tau in the cerebral cortex, and also when they focused on regions that are particularly sensitive to the early stages of Alzheimer's. The connection remained significant even after adjusting for many risk factors, including metabolic and vascular risk factors.
Conversely, no connection was found between Vitamin D levels and amyloid burden in the brain.
This difference is important. Alzheimer's is not a disease of a single marker alone. Amyloid and tau behave differently, appear at different stages, and may be affected by different biological mechanisms. Tau accumulation, especially in certain areas of the brain, is more closely linked to degenerative processes and cognitive decline.
The researchers also examined whether there was a clear difference according to a clinical threshold, for example below or above 30 ng/mL. In this analysis, the connection was less clear. The reason for this might be that relatively few participants in the study had a very significant Vitamin D deficiency, making it difficult to accurately test the effect of a true deficiency.
In additional analyses, which were defined as exploratory only, a possibility was observed that higher levels of Vitamin D are associated with less tau, but the researchers emphasized that these findings must be interpreted with caution.
How Might Vitamin D Affect the Brain?
Vitamin D is not just a "bone vitamin." Receptors for Vitamin D are found in many tissues in the body, including the nervous system. Mechanisms related to the activation of Vitamin D also exist in the brain.
There are several possible ways in which Vitamin D might affect processes related to tau. It may affect inflammation in the nervous system, oxidative stress, immune system activity, antioxidant defense, and biochemical processes that cause tau to become more problematic and accumulate in the brain.
Studies in animals and cellular models have found that Vitamin D deficiency can increase the phosphorylation of tau: A chemical change linked to its abnormal accumulation, and also increase oxidative stress. Conversely, the normal activity of Vitamin D may affect enzymes and pathways involved in the regulation of tau. These are still not proof that a Vitamin D supplement prevents dementia in humans, but they provide a possible biological explanation for the finding seen in the study.
Another important point is the timing. Many studies on dementia examine older people, sometimes after the processes in the brain have already been developing for years. This study examined Vitamin D levels at a relatively young age, a stage where there may still be a wider window of opportunity for prevention.
What Does It Mean for You?
The study does not say that everyone should start taking high doses of Vitamin D to prevent Alzheimer's. Nor does it prove that Vitamin D supplements lower tau or prevent dementia. But it does suggest that Vitamin D levels in midlife may be part of a broader puzzle of brain health.
A Vitamin D test is a simple blood test, and in many cases it makes sense to check it, especially in people with little sun exposure, obesity, intestinal diseases or absorption problems, a restricted diet, chronic diseases, or an increased risk of deficiency. Vitamin D deficiency is a common and treatable condition, but it is important to do so in a personalized manner.
Therefore, the message is not "take as much Vitamin D as possible," but rather: It is advisable to avoid prolonged deficiency, to test when there is a reason to do so, and to correct low levels in a safe and controlled manner.
One of the important messages from the study is that brain aging does not begin in old age. The biological foundation for brain health may be built decades earlier.
Brain health likely depends on a combination of many factors: Metabolic balance, blood pressure, sleep, physical activity, nutrition, inflammation, vascular health, environmental exposures, mood, social connections, and also nutritional status, including Vitamin D.
This is where the importance of a broader medical perspective comes in. Instead of waiting for memory problems to appear, it is possible to identify modifiable risk factors early and treat them. Vitamin D is not the whole story, but it may be one marker within a broader picture that includes sun exposure, inflammation, immune function, metabolism, and lifestyle.
The new study does not offer a magic solution. But it reminds us that our brain at age 70 may also be affected by what happened in our body at age 40. And sometimes, prevention begins with a simple check of what is missing.
Dr. Dalit Dreman-Medina is a specialist in family medicine and integrative and functional medicine